Program & First Confirmed Speakers

Day 1 – Thursday, June 20, 2024

Keynote Speech 2024: Phage Therapeutics 2024: The Critical Role of Translational Research in Clinical Trials 

Robert T. Schooley, University of California, San Diego, USA

Session 1: Phages, Hosts & Microbiome: On the Way to Medical Revolution

Eugene V Koonin, National Institutes of Health, USA

Wolfgang Weninger, Medical University of Vienna, Austria

Jumpei Fujiki, University of California San Diego, USA

Domenico Frezza, University of Roma Tor Vergata, Italy

 

Session 2 – Phage Therapy: Emerging Trends and Innovative Approaches

Graham F. Hatfull, University of Pittsburgh, USA

Paul Turner, Yale University, USA 

Antonia P. Sagona, University of Warwick, United Kingdom

 

Rodrigo Ibarra Chavez, University of Copenhagen, Denmark


Day 2 – Friday, June 21, 2024

Session 3: Phages Therapy 2024: From Bench to Bedside

Nannan Wu, Shanghai Public Health Clinical Center, Fudan University, China

Sabrina Green, KU Leuven, Belgium
Federica Briani, University of Milan, Italy

 

Session 4: Ethical Considerations and Regulatory Landscape of Phage Therapy: Challenges, Advocacy and Task Forces

Barbara Brenner, Kanzlei BRENNER, Germany

Jean-Paul Pirnay, Queen Astrid Military Hospital, Belgium

 

Pieter-Jan Ceyssens, Sciensano, Belgium

 

Phage Therapy 2024 Concluding Remarks

Phage Therapy 2024 Awards:
Best Phage Innovation 2024,
Best Scientific Contribution, Best Short Oral Presentation, Best Poster Presentation.

End of Targeting Phage Therapy 2024

Targeting Phage Therapy Team
LinkedIn | Facebook